A fully magnetically levitated rotor with no mechanical bearings, no blood recirculation paths inside the pump, and optimized flow to minimize blood damage.
Designed for minimally invasive implantation without open-heart surgery, featuring a very thin and flexible driveline that is one-third of the size of the HeartMate 3 to reduce infection risk.
Specifically engineered to eliminate hospital tethers and constant clinical supervision, and allow patients to return to their communities, families, work, and play while enabling recovery.
Extracorporeal Membrane Oxygenation (ECMO)
Impella CP
Intra-Aortic Balloon Pump (IABC)
Impella 5.5
Hemoglide
Impella 5.5 (limited and short-term)
Hemoglide (medium to long-term support)
Hemoglide
Later on: more invasive options, such as durable LVADs or transplants, are implemented when deemed necessary

Hemoglide gives patients a support option that aims for discharge, mobility, greater potential for recovery, and an increased quality of life with less adverse events or potential risks.

Hemoglide will present clinicians with a smaller implant strategy and a more practical care pathway.

The discharge-oriented approach of Hemoglide aligns with currently established reimbursement and hospital incentives while also saving patients money on hospital-related expenses.
Copyright © 2026 Miniscule Inc - All Rights Reserved.
Powered by GoDaddy